. Neuromodulation technology holds promise for treating conditions where physiological mechanisms of neural activity have been affected. To make treatments efficient and devices highly effective, neurostimulation protocols must be personalized. The interface between the targeted nervous tissue and the neurotechnology (i.e. human-machine link or neural interface) usually requires constant re-calibration of neuromodulation parameters, due to many different biological and microscale phenomena happening over-time. This adaptation of the optimal stimulation parameters generally involves an expert-mediated re-calibration, with corresponding economic burden, compromised every-day usability and efficacy of the device, and consequent loss of time and increased discomfort of patients going back to clinics to get the device tuned. We aim to construct an adaptable AI-based system, able to compensate for these changes autonomously.. We exploited Gaussian process-based Bayesian optimization (GPBO) methods to re-adjust the neurostimulation parameters in realistic neuroprosthetic data by integrating temporal information into the process to tackle the issue of time variability. To this aim, we built a predictive model able to tune the neuromodulation parameters in two separate crucial scenarios where re-calibration is needed. In the first one, we built a model able to find the optimal active sites in a multichannel electrode, i.e. able to cover a certain function for a neuroprosthesis, which in this specific case was the evoked-sensation location variability. In the second one, we propose an algorithm able to adapt the injected charge required to obtain a functional neural activation (e.g. perceptual threshold variability). By retrospectively collecting the outcomes from the calibration experiments in a human clinical trial utilizing implantable neuromodulation devices, we were able to quantitatively assess our GPBO-based approach in an offline setting.Our automatic algorithm can successfully adapt neurostimulation parameters to evoked-sensation location changes and to perceptual threshold changes over-time. These findings propose a quick, automatic way to tackle the inevitable variability of neurostimulation parameters over time. Upon validation in other frameworks it increases the usability of this technology through decreasing the time and the cost of the treatment supporting the potential for future widespread use. This work suggests the exploitation of AI-based methods for developing the next generation of 'smart' neuromodulation devices.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1088/1741-2552/acc975 | DOI Listing |
Echocardiography
February 2025
Department of Cardiology, MedStar Georgetown University Hospital, Washington, DC, USA.
Objective: This study evaluated the safety and efficacy of isoproterenol administration as an adjunct for achievement of target heart rate (HR) during dobutamine stress echocardiography (DSE).
Background: In DSE, optimal accuracy is achieved when a target HR of 85% of maximal predicted heart rate (MPHR) is attained. Although rarely studied, intravenous isoproterenol has been used as an adjunct therapy to dobutamine and atropine to increase chronotropic response during pharmacologic stress testing.
Neurotox Res
January 2025
Programa de Pós-Graduação em Ciências Biológicas: Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Resveratrol, a natural polyphenol, has shown promising neuroprotective effects in several in vivo and in vitro experimental models. However, the mechanisms by which resveratrol mediates these effects are not fully understood. Glutamate is the major excitatory neurotransmitter in the brain; however, excessive extracellular glutamate levels can affect neural activity in several neurological diseases.
View Article and Find Full Text PDFRev Cardiovasc Med
January 2025
Cardiology Department, Université de Mons, 7000 Mons, Belgium.
Background: Neuromodulation has been shown to increase the efficacy of atrial fibrillation (AF) ablation procedures. However, despite its ability to influence the autonomic nervous system (ANS), the exact mechanism of action remains unclear. The activity of the ANS via the intracardiac nervous system (ICNS) can be inferred from heart rate variability (HRV).
View Article and Find Full Text PDFInt J Mol Sci
January 2025
Chair and Department of Biochemistry, Medical University of Warsaw, Banacha 1, 02-097 Warszawa, Poland.
Selol is a semi-synthetic mixture of selenized triglycerides. The results of biological studies revealed that Selol exhibits several anticancer effects. However, studies on its potential anti-inflammatory activity are scarce, and underlying signaling pathways are unknown.
View Article and Find Full Text PDFInt J Environ Res Public Health
December 2024
Centre for Behavioural Research in Cancer, Cancer Council Victoria, Melbourne, VIC 3002, Australia.
Cigarette brand variant names and characteristics such as the taste and feel of the smoke can mislead consumers into believing some products are less harmful. We assessed the characteristics of three common cigarette variants sold in Australia, "gold", "blue" and "red", to determine which characteristics differed by color, and which affected tar, nicotine and carbon monoxide (TNCO) yields. TNCO yields, physical parameters, expanded tobacco and filter ventilation were measured in cigarette color variants from eight brands.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!